دورية أكاديمية

Synergistic activity of fosfomycin, β-lactams and peptidoglycan recycling inhibition against Pseudomonas aeruginosa.

التفاصيل البيبلوغرافية
العنوان: Synergistic activity of fosfomycin, β-lactams and peptidoglycan recycling inhibition against Pseudomonas aeruginosa.
المؤلفون: Hamou-Segarra, Myriam, Zamorano, Laura, Vadlamani, Grishma, Chu, Mitchell, Sanchez-Diener, Irina, Juan, Carlos, Blazquez, Jesús, Hattie, Mitchell, Stubbs, Keith A., Mark, Brian L., Oliver, Antonio
المصدر: Journal of Antimicrobial Chemotherapy (JAC); Feb2017, Vol. 72 Issue 2, p448-454, 7p
مصطلحات موضوعية: FOSFOMYCIN, ANTIBACTERIAL agents, LACTAMS, PSEUDOMONAS aeruginosa, HETEROCYCLIC compounds, CELL metabolism, PSEUDOMONAS metabolism, ACIDS, AMINES, ANTIBIOTICS, CELLS, DRUG synergism, MICROBIAL sensitivity tests, GENETIC mutation, PSEUDOMONAS, GLUCOSAMINE, ACYCLIC acids, IMIPENEM, PHARMACODYNAMICS
مستخلص: Objectives: To evaluate the interconnection between peptidoglycan (PG) recycling, fosfomycin susceptibility and synergy between fosfomycin and β-lactams in Pseudomonas aeruginosa METHODS: Fosfomycin MICs were determined by broth microdilution and Etest for a panel of 47 PAO1 mutants defective in several components of PG recycling and/or AmpC induction pathways. PAO1 fosfomycin MICs were also determined in the presence of a 5 mM concentration of the NagZ inhibitor PUGNAc. Population analysis of fosfomycin susceptibility and characterization of the resistant mutants that emerged was also performed for selected strains. Finally, fosfomycin, imipenem and fosfomycin + imipenem killing curves were assessed.Results: Mutants defective in AmpG, NagZ or all three AmpD amidases showed a marked increase in fosfomycin susceptibility (at least two 2-fold dilutions with respect to WT PAO1). Moreover, PAO1 fosfomycin MICs were consistently reduced from 48 to 24 mg/L in the presence of a 5 mM concentration of PUGNAc. Fosfomycin hypersusceptibility of the ampG, nagZ and triple ampD mutants was also clearly confirmed in the performed population analysis, although the emergence of resistant mutants, through GlpT mutations, was not avoided. Synergy between fosfomycin and imipenem was evidenced for the WT strain, the AmpC-hyperproducing strain (triple AmpD mutant) and the NagZ and AmpG mutants in killing curves. Moreover, regrowth of resistant mutants was not evidenced for the combination.Conclusions: PG recycling inhibitors are envisaged as useful adjuvants in the treatment of P. aeruginosa infections with β-lactams and fosfomycin and therefore further development of these molecules is encouraged. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Antimicrobial Chemotherapy (JAC) is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:03057453
DOI:10.1093/jac/dkw456